Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma
Leukemia. 2022 Feb;36(2):583-587. doi: 10.1038/s41375-021-01389-w.…
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma
Transplant Cell Ther. 2021 Sep;27(9):720-728. doi: 10.1016/j.jtct.2021.03.001.ABSTRACTAutologous…
Is Post-Transplant Cyclophosphamide the New Methotrexate?
J Clin Med. 2021 Aug 12;10(16):3548. doi: 10.3390/jcm10163548.ABSTRACTIntroducing…
Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer
Cancers (Basel). 2021 Aug 19;13(16):4168. doi: 10.3390/cancers13164168.ABSTRACTThe…
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Cancers (Basel). 2021 Aug 9;13(16):4009. doi: 10.3390/cancers13164009.ABSTRACTThe…
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants
Hum Mutat. 2021 Nov;42(11):1488-1502. doi: 10.1002/humu.24276.…
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Bone Marrow Transplant. 2021 Dec;56(12):2911-2921. doi: 10.1038/s41409-021-01288-9.…
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
Mol Ther Oncolytics. 2021 May 29;22:27-35. doi: 10.1016/j.omto.2021.05.009.…
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Blood. 2021 Nov 11;138(19):1901-1905. doi: 10.1182/blood.2021012319.NO…
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale
Br J Clin Pharmacol. 2022 Feb;88(2):742-752. doi: 10.1111/bcp.15015.…
